Freedom of information requests

Treatment of Melanoma & RRC

Questions

1. How many patients have been treated in the past 3 months with the following agents for renal cell carcinoma (any stage):
2. How many patients have been treated in the past 3 months with the following agents for melanoma (any stage) :
3. Does you trust participate in any clinical trials for the treatment of melanoma? If so please provide the name of each trial and number of patients that are taking part?

Response

1. Exemption applied Section 40 (2)
   

   Drug	No. of Patients
   Avelumab + Axitinib	<6
   Axinitib	0
   Cabozantinib	0
   Everolimus	0
   Lenvantinib + Everolimus	0
   Nivolumab monotherapy	0
   Nivolumab + Cabozantinib	0
   Nivolumab + Ipilimumab	0
   Pazopanib	0
   Pembrolizumab monotherapy	<6
   Pembrolizumab + Lenvatinib	0
   Pembrolizumab + Axitinib	<6
   Radiotherapy only	0
   Sunitinib	0
   Temsirolimus	0
   Tivozanib	0
   Other active systemic anti-cancer therapy	0
   Palliative care only	0

2. Exemption applied Section 40 (2)
   

   Drug	No. of Patients
   Cobimetinib	0
   Dabrafenib	0
   Dabrafenib + Trametinib	0
   Dacarbazine	0
   Denosumab	0
   Encorafenib + Binimetinib	0
   Ipilimumab monotherapy	0
   Ipilimumab + Nivolumab	0
   Nivolumab monotherapy	<6
   Nivolumab + Relatlimab	<6
   Pembrolizumab	0
   Trametinib	0
   Vemurafenib	0
   Vemurafenib + Cobimetinib	0
   Other active systemic anti-cancer therapy	0
   Palliative care only	0

3. The name of the trial is exempt under S41 of FOIA.  There are two trials open to recruitment with 17 participants recruited.

The Trust does hold all of the information you have requested, however we are withholding some of it for the following reasons:

 

Section 40 – Personal Information

Section 40 (2) of the Freedom of Information Act (2000) allows public authorities to withhold personal data where it is protected under the Data Protection Act.

“Personal data” means any information relating to an identified living individual.

We have therefore withheld the exact number of patients where this is 5 or less (replaced with the <6 symbol), as this could be potentially identifiable and as such is protected from disclosure by Section 40 (2) of the FOI Act.

 

Section 41 Information Provided in confidence.

We are unable to disclose this information into the public domain as it would be likely to constitute a breach of confidence. This information was provided to us by companies with the assumption that the Trust would not share it.

Section 41 of the Freedom of Information Act has been applied. This is an absolute exemption on disclosure and therefore the public interest test does not need be applied.